Back to search

Democritus University of Thrace (DUTH)

Πολυμορφισμοί του ενζύμου 11β υδροξυστεροϊδική δεϋδρογενάση και καρδιαγγειακοί παράγοντες κινδύνου σε παχύσαρκους ασθενείς

Abstract

dc:description

Backgrouds/Aims: Obesity shares some of the clinical manifestations of diseases with high glucocorticoid levels. The 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1), is a enzyme that reversibly catalyzes the conversion of cortisol to cortisone and also the reverse reaction, when levels of Nicotinamide adenine dinucleo-tide (NADH) are low. It has been hypothesized that “pre-receptor” activation of cortisol from inactive cortisone could lead to central obesity with normal circulating cortisol concentration. Changes in the local concentration of glucocorticoids due to 11b-HSD1 activity were implicated in obesity, insulin resistance, and type 2 Diabetes Mellitus. Several studies investigated possible roles for 11b-HSD1 gene single nucleotide polymorphisms in altered glucocorticoid metabolism and obesity, providing conflicting results. Thus, the aim of the present study was to investigate possible associations of a frequent single nucleotide polymorphisms of the 11b-HSD1 gene, the insertion of adenine at 209706872 position in a Greek population with metabolic syndrome.Materials and Methods: This study included in total 309 obese patients and 102 healthy controls (group C, 30 male, mean age 55.2 ± 14.5 years). 220 (71.2%) obese patients had Metabolic Syndrome (NCEP-ATP criteria) (group A, 88 male, mean age 60.4 ± 12.5 years) and 89 (28.8%) obese patients did not meet the criteria for having Metabolic Syndrome (group B, 34 male, mean age 55.2 ± 13.9 years) and were characterized as obese non-MS. All subjects were genotyped for the 2556dupA polymorphism. Cortisol, fasting glucose, HbA1c, serum lipids and uric acid were measured. In addition we measured waist and hip circumference, BMI and Ankle Branchial Index (ABI).Results: The overall frequency of 255669dupA was 14.48%. Patients with Metabolic Syndrome and glucose intolerance had 10.5% higher polymorphism rate (p=0,017) and patients with Diabetes Mellitus had 9.3% higher polymorphism rate (p=0.09). The presence of the under study polymorphism was not associated with increased cortisol levels (p=0.523).The presence of the 25669dupA SNP of the 11b HSD 1 gene was not associated with obesity [obese vs healthy: OR=1,6, 95% CI (0.47, 5,39), p=0.445] or with the Metabolic Syndrome [ MetS vs non-MetS: OR=2.65, 95% CI (0.852, 8.210), p=0.092]. Conclusions: The 25669dupA SNP of the 11b-HSD1 gene was not associated with obesity, metabolic syndrome, glucose intolerance or Diabetes Mellitus in greek obese patients. In total there was no proven effect of the polymorphism on the phenotype of the Metabolic Syndrome, although there is a possible weak effect on insulin resistance. Replication studies are needed to delineate a possible association of the 11b HSD1 polymorphisms with obesity and Metabolic Syndrome.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kaitozis, Odysseas
  • Καϊτόζης, Οδυσσέας

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/49716

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kaitozis, Odysseas; Καϊτόζης, Οδυσσέας. Πολυμορφισμοί του ενζύμου 11β υδροξυστεροϊδική δεϋδρογενάση και καρδιαγγειακοί παράγοντες κινδύνου σε παχύσαρκους ασθενείς. Democritus University of Thrace (DUTH), 2021. http://hdl.handle.net/10442/hedi/49716